Paliperidone Palmitate. 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one . 9-Hydroxy-risperidone . 9-Hydroxyrisperidone . 9-OH-risperidone . Invega . Invega Sustenna . Paliperidone . R 76477 . R-76477 . 9 Hydroxy risperidone . 9 Hydroxyrisperidone . 9 OH risperidone . Palmitate, Paliperidone . R76477 . Sustenna, Invega . A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA. . 1.00
Aripiprazole. 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone . Abilify . Aripiprazol . OPC 14597 . OPC-14597 . 14597, OPC . An antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. . 0.66
Risperidone. R-64,766 . R-64766 . Risperdal Consta . Risperidal . Consta, Risperdal . R 64,766 . R 64766 . R64,766 . R64766 . A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. . 0.63
Lurasidone Hydrochloride. Latuda . Lurasidone . Lurasidone HCl . N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide . SM 13496 . SM-13,496 . SM-13496 . SM13496 . 13496, SM . HCl, Lurasidone . Hydrochloride, Lurasidone . SM 13,496 . SM13,496 . A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic alpha2A and alpha2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER. . 0.61
Androgen Receptor Antagonists. Antagonists, Androgen Receptor . Receptor Antagonists, Androgen . Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. . 0.54
Dopamine D2 Receptor Antagonists. Dopamine D2 Antagonists . Receptor Antagonists, Dopamine D2 . Antagonists, Dopamine D2 . D2 Antagonists, Dopamine . Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. . 0.53
Serotonin 5-HT2 Receptor Antagonists. 5-HT2 Antagonist . 5-HT2A Antagonist . 5-HT2B Antagonist . 5-HT2C Antagonist . Serotonin 5-HT2A Receptor Antagonists . Serotonin 5-HT2B Receptor Antagonists . Serotonin 5-HT2C Receptor Antagonists . 5 HT2 Antagonist . 5 HT2A Antagonist . 5 HT2B Antagonist . 5 HT2C Antagonist . Antagonist, 5-HT2 . Antagonist, 5-HT2A . Antagonist, 5-HT2B . Antagonist, 5-HT2C . Serotonin 5 HT2 Receptor Antagonists . Serotonin 5 HT2A Receptor Antagonists . Serotonin 5 HT2B Receptor Antagonists . Serotonin 5 HT2C Receptor Antagonists . Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. . 0.52
